| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatocytes | 46 | 2019 | 1247 | 5.920 |
Why?
|
| Nanoparticles | 28 | 2018 | 1964 | 3.340 |
Why?
|
| Tissue Engineering | 25 | 2017 | 1855 | 3.140 |
Why?
|
| RNA, Small Interfering | 16 | 2019 | 3421 | 2.530 |
Why?
|
| Liver | 33 | 2019 | 7562 | 2.530 |
Why?
|
| Polyethylene Glycols | 15 | 2018 | 1188 | 2.300 |
Why?
|
| Cell Culture Techniques | 19 | 2018 | 1652 | 2.270 |
Why?
|
| Nanotechnology | 9 | 2015 | 703 | 1.460 |
Why?
|
| Coculture Techniques | 17 | 2018 | 1336 | 1.330 |
Why?
|
| Hydrogels | 8 | 2015 | 728 | 1.300 |
Why?
|
| Peptide Hydrolases | 5 | 2018 | 608 | 1.300 |
Why?
|
| Nanomedicine | 6 | 2015 | 286 | 1.280 |
Why?
|
| Microfluidics | 10 | 2014 | 651 | 1.270 |
Why?
|
| Liver, Artificial | 5 | 2015 | 55 | 1.140 |
Why?
|
| Plasmodium | 6 | 2019 | 248 | 1.130 |
Why?
|
| Malaria | 10 | 2019 | 1246 | 1.120 |
Why?
|
| Plasmodium vivax | 4 | 2018 | 202 | 1.100 |
Why?
|
| Biosensing Techniques | 8 | 2018 | 642 | 1.090 |
Why?
|
| Neoplasms, Experimental | 4 | 2018 | 1229 | 1.070 |
Why?
|
| Cell Communication | 9 | 2014 | 1660 | 1.050 |
Why?
|
| Microfluidic Analytical Techniques | 8 | 2013 | 788 | 0.990 |
Why?
|
| Hepatitis B virus | 4 | 2017 | 530 | 0.960 |
Why?
|
| Nanostructures | 7 | 2014 | 548 | 0.960 |
Why?
|
| Biocompatible Materials | 13 | 2012 | 1682 | 0.930 |
Why?
|
| Mice, Nude | 17 | 2019 | 3618 | 0.910 |
Why?
|
| Drug Carriers | 8 | 2010 | 700 | 0.890 |
Why?
|
| Silicon | 9 | 2017 | 141 | 0.880 |
Why?
|
| Hepacivirus | 5 | 2016 | 1343 | 0.880 |
Why?
|
| Mice | 76 | 2019 | 81818 | 0.840 |
Why?
|
| Antimalarials | 7 | 2018 | 913 | 0.830 |
Why?
|
| Culture Techniques | 4 | 2007 | 515 | 0.830 |
Why?
|
| Induced Pluripotent Stem Cells | 7 | 2016 | 1883 | 0.820 |
Why?
|
| Peptides | 11 | 2017 | 4331 | 0.810 |
Why?
|
| Animals | 111 | 2019 | 168759 | 0.810 |
Why?
|
| Life Cycle Stages | 5 | 2018 | 161 | 0.810 |
Why?
|
| Rats, Inbred Lew | 15 | 2015 | 1167 | 0.770 |
Why?
|
| High-Throughput Screening Assays | 4 | 2016 | 938 | 0.740 |
Why?
|
| Quantum Dots | 5 | 2010 | 168 | 0.700 |
Why?
|
| Hepatitis C | 6 | 2016 | 1597 | 0.690 |
Why?
|
| RNA Interference | 4 | 2019 | 2832 | 0.680 |
Why?
|
| Liver Diseases | 3 | 2017 | 1303 | 0.670 |
Why?
|
| Cells, Cultured | 30 | 2015 | 18973 | 0.670 |
Why?
|
| Extracellular Matrix | 9 | 2016 | 1727 | 0.670 |
Why?
|
| Hyperthermia, Induced | 3 | 2015 | 415 | 0.670 |
Why?
|
| Drug Discovery | 5 | 2019 | 1064 | 0.660 |
Why?
|
| 3T3 Cells | 9 | 2019 | 1081 | 0.650 |
Why?
|
| Ovarian Neoplasms | 7 | 2016 | 4900 | 0.630 |
Why?
|
| Metal Nanoparticles | 3 | 2014 | 403 | 0.630 |
Why?
|
| Molecular Imaging | 2 | 2016 | 822 | 0.620 |
Why?
|
| Cell Line, Tumor | 30 | 2018 | 17075 | 0.620 |
Why?
|
| Stromal Cells | 4 | 2019 | 1329 | 0.620 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2018 | 43 | 0.600 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2018 | 90 | 0.590 |
Why?
|
| Fibroblasts | 10 | 2018 | 4159 | 0.560 |
Why?
|
| Plasmodium falciparum | 8 | 2019 | 1738 | 0.540 |
Why?
|
| Pluripotent Stem Cells | 2 | 2014 | 807 | 0.510 |
Why?
|
| Electrophoresis | 2 | 2007 | 226 | 0.510 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 1599 | 0.510 |
Why?
|
| Virus Replication | 5 | 2017 | 2447 | 0.500 |
Why?
|
| Gene Library | 1 | 2018 | 1067 | 0.500 |
Why?
|
| Drug Delivery Systems | 14 | 2016 | 2207 | 0.500 |
Why?
|
| Galectin 3 | 2 | 2014 | 238 | 0.490 |
Why?
|
| Host-Pathogen Interactions | 4 | 2018 | 1461 | 0.490 |
Why?
|
| Models, Biological | 10 | 2018 | 9443 | 0.490 |
Why?
|
| Magnetite Nanoparticles | 2 | 2016 | 309 | 0.490 |
Why?
|
| Oligopeptides | 3 | 2018 | 1192 | 0.480 |
Why?
|
| Surface Plasmon Resonance | 2 | 2013 | 268 | 0.480 |
Why?
|
| Bioreactors | 6 | 2012 | 244 | 0.470 |
Why?
|
| Gene Expression Profiling | 6 | 2018 | 9524 | 0.470 |
Why?
|
| Rats | 29 | 2016 | 23707 | 0.470 |
Why?
|
| Sialyltransferases | 1 | 2014 | 83 | 0.460 |
Why?
|
| Transfection | 3 | 2012 | 5743 | 0.460 |
Why?
|
| Matrix Metalloproteinases | 1 | 2016 | 392 | 0.440 |
Why?
|
| Artificial Organs | 2 | 2014 | 149 | 0.440 |
Why?
|
| Sporozoites | 5 | 2019 | 83 | 0.430 |
Why?
|
| Cell Differentiation | 12 | 2016 | 11640 | 0.430 |
Why?
|
| Neoplasms | 19 | 2018 | 22340 | 0.430 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2014 | 168 | 0.430 |
Why?
|
| Parasitology | 1 | 2013 | 28 | 0.430 |
Why?
|
| Gold | 4 | 2014 | 482 | 0.430 |
Why?
|
| Cell Hypoxia | 2 | 2006 | 647 | 0.420 |
Why?
|
| Electromagnetic Fields | 5 | 2007 | 290 | 0.420 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2012 | 17 | 0.410 |
Why?
|
| Small Molecule Libraries | 3 | 2018 | 741 | 0.410 |
Why?
|
| Magnetics | 7 | 2009 | 585 | 0.400 |
Why?
|
| Doxorubicin | 6 | 2015 | 2230 | 0.400 |
Why?
|
| Microbiological Techniques | 1 | 2013 | 96 | 0.400 |
Why?
|
| HeLa Cells | 8 | 2016 | 3067 | 0.390 |
Why?
|
| Genome, Viral | 1 | 2016 | 670 | 0.390 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2014 | 216 | 0.390 |
Why?
|
| Albumins | 6 | 2017 | 577 | 0.390 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2015 | 679 | 0.380 |
Why?
|
| Thrombosis | 4 | 2014 | 2949 | 0.380 |
Why?
|
| Hemorheology | 1 | 2012 | 144 | 0.380 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2008 | 462 | 0.380 |
Why?
|
| Nanocapsules | 1 | 2012 | 92 | 0.370 |
Why?
|
| Probiotics | 1 | 2015 | 387 | 0.360 |
Why?
|
| Silicon Dioxide | 2 | 2011 | 217 | 0.360 |
Why?
|
| Salmonella typhimurium | 1 | 2013 | 348 | 0.360 |
Why?
|
| Blood Coagulation | 2 | 2014 | 1166 | 0.360 |
Why?
|
| Disease Models, Animal | 10 | 2018 | 18294 | 0.360 |
Why?
|
| Gene Targeting | 2 | 2015 | 841 | 0.350 |
Why?
|
| Humans | 110 | 2019 | 765956 | 0.350 |
Why?
|
| Bacterial Infections | 1 | 2018 | 1387 | 0.350 |
Why?
|
| Phototherapy | 1 | 2013 | 370 | 0.340 |
Why?
|
| Microtechnology | 1 | 2010 | 64 | 0.340 |
Why?
|
| Cell Survival | 13 | 2015 | 5746 | 0.340 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2013 | 618 | 0.330 |
Why?
|
| DNA, Single-Stranded | 1 | 2011 | 353 | 0.320 |
Why?
|
| Nanotubes | 2 | 2010 | 83 | 0.320 |
Why?
|
| Dendrimers | 1 | 2009 | 72 | 0.320 |
Why?
|
| Cell Adhesion | 10 | 2016 | 3089 | 0.320 |
Why?
|
| Porosity | 7 | 2017 | 347 | 0.310 |
Why?
|
| Colorectal Neoplasms | 4 | 2016 | 6942 | 0.310 |
Why?
|
| Hot Temperature | 1 | 2015 | 1433 | 0.310 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 735 | 0.310 |
Why?
|
| Oncogenes | 3 | 2018 | 1235 | 0.310 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 1308 | 0.300 |
Why?
|
| DNA, Viral | 1 | 2015 | 2199 | 0.300 |
Why?
|
| Host-Parasite Interactions | 4 | 2019 | 302 | 0.300 |
Why?
|
| Materials Testing | 7 | 2009 | 868 | 0.300 |
Why?
|
| Microarray Analysis | 2 | 2016 | 752 | 0.300 |
Why?
|
| Surface Properties | 8 | 2009 | 1151 | 0.290 |
Why?
|
| Flow Injection Analysis | 1 | 2007 | 21 | 0.290 |
Why?
|
| Anemia, Sickle Cell | 3 | 2012 | 1067 | 0.290 |
Why?
|
| Micromanipulation | 2 | 2004 | 53 | 0.290 |
Why?
|
| Delayed-Action Preparations | 1 | 2011 | 967 | 0.290 |
Why?
|
| Equipment Design | 10 | 2013 | 3481 | 0.290 |
Why?
|
| Bacteria | 1 | 2018 | 2209 | 0.290 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2009 | 314 | 0.280 |
Why?
|
| Drug Design | 2 | 2014 | 1042 | 0.280 |
Why?
|
| Cell Line | 10 | 2018 | 15543 | 0.280 |
Why?
|
| Chemistry, Physical | 1 | 2007 | 152 | 0.280 |
Why?
|
| Homeostasis | 2 | 2015 | 3336 | 0.270 |
Why?
|
| Cattle | 6 | 2014 | 3801 | 0.270 |
Why?
|
| Cell Biology | 1 | 2007 | 91 | 0.270 |
Why?
|
| Polymers | 4 | 2011 | 1621 | 0.260 |
Why?
|
| Cadherins | 2 | 2008 | 900 | 0.260 |
Why?
|
| Cell Proliferation | 9 | 2019 | 10429 | 0.260 |
Why?
|
| Pancreatic Neoplasms | 3 | 2018 | 5444 | 0.260 |
Why?
|
| Peptides, Cyclic | 1 | 2008 | 390 | 0.260 |
Why?
|
| Neoplasm Transplantation | 6 | 2018 | 2014 | 0.260 |
Why?
|
| Fluorescent Dyes | 4 | 2014 | 1930 | 0.260 |
Why?
|
| Endothelium, Vascular | 2 | 2015 | 4427 | 0.250 |
Why?
|
| Electronics | 1 | 2007 | 314 | 0.250 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2005 | 833 | 0.250 |
Why?
|
| Oxygen | 8 | 2015 | 4241 | 0.250 |
Why?
|
| Cytochrome P-450 Enzyme System | 3 | 2016 | 423 | 0.250 |
Why?
|
| Cytological Techniques | 2 | 2010 | 220 | 0.240 |
Why?
|
| Methylcholanthrene | 1 | 2005 | 30 | 0.240 |
Why?
|
| Point-of-Care Systems | 1 | 2014 | 1217 | 0.240 |
Why?
|
| Malaria, Vivax | 2 | 2018 | 168 | 0.240 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 1792 | 0.240 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2005 | 88 | 0.240 |
Why?
|
| Endothelial Cells | 4 | 2015 | 3584 | 0.230 |
Why?
|
| Biological Assay | 1 | 2007 | 627 | 0.230 |
Why?
|
| Ferric Compounds | 6 | 2016 | 368 | 0.230 |
Why?
|
| Malaria, Falciparum | 3 | 2019 | 1075 | 0.230 |
Why?
|
| Toxicity Tests | 1 | 2004 | 111 | 0.230 |
Why?
|
| Molecular Probe Techniques | 1 | 2005 | 111 | 0.230 |
Why?
|
| Tumor Microenvironment | 2 | 2019 | 3946 | 0.230 |
Why?
|
| Receptors, Cell Surface | 2 | 2017 | 2817 | 0.230 |
Why?
|
| Tissue Distribution | 3 | 2016 | 2266 | 0.220 |
Why?
|
| Biopolymers | 1 | 2004 | 181 | 0.220 |
Why?
|
| Microscopy, Fluorescence | 5 | 2016 | 2627 | 0.220 |
Why?
|
| Vascular Diseases | 1 | 2012 | 1159 | 0.220 |
Why?
|
| Pseudomonas Infections | 2 | 2018 | 622 | 0.220 |
Why?
|
| Tissue Scaffolds | 3 | 2017 | 934 | 0.210 |
Why?
|
| Enzyme Inhibitors | 4 | 2015 | 3715 | 0.210 |
Why?
|
| Fibronectins | 3 | 2013 | 719 | 0.210 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 7478 | 0.210 |
Why?
|
| Models, Chemical | 1 | 2004 | 608 | 0.200 |
Why?
|
| Equipment Failure Analysis | 3 | 2013 | 834 | 0.200 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2019 | 3608 | 0.200 |
Why?
|
| Gene Transfer Techniques | 1 | 2007 | 1216 | 0.200 |
Why?
|
| Tissue Array Analysis | 2 | 2015 | 545 | 0.200 |
Why?
|
| Poloxamer | 1 | 2002 | 56 | 0.190 |
Why?
|
| Particle Size | 6 | 2009 | 1631 | 0.190 |
Why?
|
| Substrate Specificity | 3 | 2018 | 1752 | 0.190 |
Why?
|
| Hepatitis B | 3 | 2017 | 707 | 0.190 |
Why?
|
| Polyglycolic Acid | 1 | 2003 | 406 | 0.190 |
Why?
|
| Bioartificial Organs | 1 | 2001 | 46 | 0.190 |
Why?
|
| Phenotype | 7 | 2018 | 16721 | 0.180 |
Why?
|
| Liver Transplantation | 2 | 2011 | 2412 | 0.180 |
Why?
|
| Collagen | 6 | 2015 | 2618 | 0.180 |
Why?
|
| Laminin | 3 | 2016 | 404 | 0.180 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 3236 | 0.180 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2018 | 1276 | 0.170 |
Why?
|
| Models, Theoretical | 1 | 2012 | 3564 | 0.170 |
Why?
|
| Fluorescence | 4 | 2011 | 753 | 0.170 |
Why?
|
| Perfusion | 2 | 2016 | 1407 | 0.160 |
Why?
|
| Kinetics | 3 | 2018 | 6274 | 0.160 |
Why?
|
| Ecdysterone | 1 | 2019 | 13 | 0.160 |
Why?
|
| Insect Vectors | 2 | 2019 | 136 | 0.160 |
Why?
|
| Gene Silencing | 3 | 2017 | 1505 | 0.160 |
Why?
|
| Adenocarcinoma | 2 | 2018 | 6364 | 0.160 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 3819 | 0.150 |
Why?
|
| Lung Neoplasms | 2 | 2014 | 13451 | 0.150 |
Why?
|
| Anticoagulants | 1 | 2014 | 4862 | 0.150 |
Why?
|
| ROC Curve | 2 | 2018 | 3620 | 0.150 |
Why?
|
| Acids | 1 | 2019 | 125 | 0.150 |
Why?
|
| Biotin | 2 | 2011 | 257 | 0.150 |
Why?
|
| Female | 36 | 2019 | 396101 | 0.150 |
Why?
|
| DNA | 3 | 2009 | 7202 | 0.150 |
Why?
|
| Crystallization | 4 | 2009 | 521 | 0.150 |
Why?
|
| Lactic Acid | 1 | 2003 | 1137 | 0.150 |
Why?
|
| Anopheles | 2 | 2019 | 193 | 0.150 |
Why?
|
| Cell Movement | 2 | 2013 | 5194 | 0.150 |
Why?
|
| Hep G2 Cells | 3 | 2017 | 379 | 0.140 |
Why?
|
| Plasmodium berghei | 2 | 2016 | 161 | 0.140 |
Why?
|
| Stem Cells | 2 | 2007 | 3540 | 0.140 |
Why?
|
| Caco-2 Cells | 2 | 2015 | 366 | 0.140 |
Why?
|
| Neoplasm Metastasis | 5 | 2019 | 4893 | 0.130 |
Why?
|
| Biotechnology | 2 | 2016 | 284 | 0.130 |
Why?
|
| Malaria Vaccines | 1 | 2018 | 165 | 0.130 |
Why?
|
| Photolysis | 1 | 2016 | 94 | 0.130 |
Why?
|
| Calcium Compounds | 1 | 2016 | 40 | 0.130 |
Why?
|
| Silicates | 1 | 2016 | 49 | 0.130 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2016 | 684 | 0.130 |
Why?
|
| Bacteriolysis | 1 | 2016 | 51 | 0.130 |
Why?
|
| Biomedical Research | 3 | 2017 | 3458 | 0.130 |
Why?
|
| Transferrin | 1 | 2017 | 283 | 0.130 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2017 | 299 | 0.130 |
Why?
|
| Genes, Reporter | 2 | 2010 | 1524 | 0.130 |
Why?
|
| Health Planning | 1 | 2017 | 233 | 0.130 |
Why?
|
| Acetaminophen | 2 | 2014 | 547 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2018 | 640 | 0.130 |
Why?
|
| Salmonella | 1 | 2016 | 122 | 0.130 |
Why?
|
| Neglected Diseases | 1 | 2016 | 67 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 11083 | 0.130 |
Why?
|
| Photochemical Processes | 1 | 2015 | 84 | 0.120 |
Why?
|
| Parasites | 1 | 2018 | 159 | 0.120 |
Why?
|
| Vestibule, Labyrinth | 1 | 2017 | 234 | 0.120 |
Why?
|
| Glucose Transporter Type 1 | 2 | 2006 | 185 | 0.120 |
Why?
|
| Miniaturization | 2 | 2007 | 150 | 0.120 |
Why?
|
| Ligands | 3 | 2013 | 3273 | 0.120 |
Why?
|
| Signal Transduction | 5 | 2019 | 23600 | 0.120 |
Why?
|
| Azetidines | 1 | 2016 | 150 | 0.120 |
Why?
|
| DNA, Circular | 1 | 2015 | 97 | 0.120 |
Why?
|
| Endoderm | 1 | 2016 | 165 | 0.120 |
Why?
|
| Mice, Transgenic | 4 | 2015 | 9550 | 0.120 |
Why?
|
| Cell Transplantation | 1 | 2017 | 473 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2016 | 1333 | 0.120 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2016 | 1306 | 0.120 |
Why?
|
| Bacteriophage M13 | 1 | 2014 | 39 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2006 | 4034 | 0.120 |
Why?
|
| Liposomes | 2 | 2016 | 788 | 0.120 |
Why?
|
| Erythrocytes | 3 | 2018 | 2395 | 0.120 |
Why?
|
| Health Priorities | 1 | 2017 | 382 | 0.120 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2016 | 226 | 0.120 |
Why?
|
| Body Patterning | 2 | 2016 | 633 | 0.120 |
Why?
|
| Time Factors | 9 | 2015 | 40065 | 0.110 |
Why?
|
| Blood Viscosity | 2 | 2012 | 125 | 0.110 |
Why?
|
| Cells, Immobilized | 1 | 2014 | 35 | 0.110 |
Why?
|
| Forecasting | 3 | 2017 | 2936 | 0.110 |
Why?
|
| beta-Galactosidase | 1 | 2015 | 572 | 0.110 |
Why?
|
| Mice, Inbred NOD | 2 | 2015 | 1837 | 0.110 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2015 | 173 | 0.110 |
Why?
|
| Nanotubes, Carbon | 1 | 2014 | 71 | 0.110 |
Why?
|
| Gene Expression | 4 | 2019 | 7584 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 8611 | 0.110 |
Why?
|
| Base Sequence | 3 | 2016 | 12403 | 0.110 |
Why?
|
| Partial Pressure | 1 | 2013 | 245 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 2019 | 1107 | 0.110 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2017 | 647 | 0.110 |
Why?
|
| Bioengineering | 1 | 2014 | 97 | 0.110 |
Why?
|
| Mice, SCID | 2 | 2015 | 2630 | 0.110 |
Why?
|
| Administration, Oral | 3 | 2016 | 4015 | 0.110 |
Why?
|
| Phosphatidylcholines | 1 | 2014 | 403 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 5 | 2019 | 6220 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 595 | 0.100 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 435 | 0.100 |
Why?
|
| Deoxycytidine | 1 | 2017 | 889 | 0.100 |
Why?
|
| Liver Neoplasms | 3 | 2019 | 4353 | 0.100 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2012 | 55 | 0.100 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 1017 | 0.100 |
Why?
|
| Printing | 1 | 2012 | 47 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2015 | 2477 | 0.100 |
Why?
|
| Neurilemmoma | 1 | 2017 | 522 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 11888 | 0.100 |
Why?
|
| Organoids | 1 | 2018 | 739 | 0.100 |
Why?
|
| Infrared Rays | 1 | 2013 | 246 | 0.100 |
Why?
|
| Cell Compartmentation | 1 | 2013 | 384 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2017 | 2476 | 0.100 |
Why?
|
| Protozoan Proteins | 1 | 2018 | 843 | 0.100 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2016 | 426 | 0.100 |
Why?
|
| Estrogens | 1 | 2019 | 1529 | 0.100 |
Why?
|
| Immunoassay | 2 | 2014 | 741 | 0.100 |
Why?
|
| Mitosis | 2 | 2014 | 1173 | 0.100 |
Why?
|
| NIH 3T3 Cells | 2 | 2019 | 651 | 0.100 |
Why?
|
| Thrombin | 1 | 2014 | 602 | 0.100 |
Why?
|
| Subcutaneous Tissue | 1 | 2012 | 130 | 0.100 |
Why?
|
| Antisickling Agents | 1 | 2012 | 72 | 0.100 |
Why?
|
| Oxygen Consumption | 3 | 2004 | 1870 | 0.100 |
Why?
|
| Light | 2 | 2016 | 1364 | 0.090 |
Why?
|
| Thromboplastin | 1 | 2013 | 289 | 0.090 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2013 | 306 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4562 | 0.090 |
Why?
|
| Glycosylation | 1 | 2014 | 1100 | 0.090 |
Why?
|
| Molecular Structure | 2 | 2013 | 1885 | 0.090 |
Why?
|
| Adenoviridae | 2 | 2006 | 1092 | 0.090 |
Why?
|
| Estradiol | 1 | 2019 | 1947 | 0.090 |
Why?
|
| Streptavidin | 1 | 2011 | 81 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 372 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 1241 | 0.090 |
Why?
|
| Cytosol | 2 | 2016 | 885 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2012 | 5020 | 0.090 |
Why?
|
| Membranes, Artificial | 2 | 2003 | 362 | 0.090 |
Why?
|
| Cryopreservation | 1 | 2016 | 728 | 0.090 |
Why?
|
| Genes, Essential | 1 | 2012 | 185 | 0.090 |
Why?
|
| Peptide Library | 1 | 2012 | 351 | 0.090 |
Why?
|
| Coumarins | 1 | 2011 | 120 | 0.090 |
Why?
|
| Micelles | 2 | 2010 | 188 | 0.090 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 2218 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 2060 | 0.090 |
Why?
|
| Blood Flow Velocity | 2 | 2012 | 1381 | 0.090 |
Why?
|
| Luciferases, Renilla | 1 | 2010 | 22 | 0.090 |
Why?
|
| HMGB Proteins | 1 | 2010 | 45 | 0.090 |
Why?
|
| SOXF Transcription Factors | 1 | 2010 | 31 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2242 | 0.090 |
Why?
|
| Comet Assay | 1 | 2010 | 74 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1761 | 0.090 |
Why?
|
| Pulmonary Embolism | 2 | 2014 | 2598 | 0.090 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 13400 | 0.090 |
Why?
|
| Biomimetic Materials | 1 | 2012 | 170 | 0.090 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 21056 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 3796 | 0.080 |
Why?
|
| Plasmids | 1 | 2015 | 2274 | 0.080 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2035 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 2505 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2017 | 5337 | 0.080 |
Why?
|
| Triazoles | 1 | 2015 | 897 | 0.080 |
Why?
|
| Blood-Brain Barrier | 1 | 2016 | 1037 | 0.080 |
Why?
|
| Pattern Recognition, Automated | 1 | 2015 | 978 | 0.080 |
Why?
|
| Solutions | 2 | 2014 | 403 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2018 | 1758 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 2 | 2015 | 1375 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2014 | 1417 | 0.080 |
Why?
|
| Cell Separation | 2 | 2005 | 1718 | 0.080 |
Why?
|
| Image Enhancement | 2 | 2010 | 2858 | 0.080 |
Why?
|
| Contrast Media | 2 | 2014 | 5329 | 0.080 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 454 | 0.080 |
Why?
|
| Galectins | 1 | 2012 | 294 | 0.080 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 488 | 0.080 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2010 | 429 | 0.080 |
Why?
|
| Vascular Resistance | 1 | 2012 | 941 | 0.080 |
Why?
|
| Antiviral Agents | 3 | 2016 | 3050 | 0.080 |
Why?
|
| bcl-X Protein | 1 | 2010 | 414 | 0.080 |
Why?
|
| Doxycycline | 1 | 2010 | 349 | 0.070 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 1105 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 2845 | 0.070 |
Why?
|
| Azides | 1 | 2008 | 120 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 5 | 2016 | 22331 | 0.070 |
Why?
|
| Genomic Instability | 1 | 2012 | 718 | 0.070 |
Why?
|
| Electrolytes | 1 | 2008 | 280 | 0.070 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 3051 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2010 | 5881 | 0.070 |
Why?
|
| RNA, Viral | 1 | 2016 | 2864 | 0.070 |
Why?
|
| Swiss 3T3 Cells | 1 | 2007 | 6 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 2 | 2012 | 1352 | 0.070 |
Why?
|
| Equipment Reuse | 1 | 2007 | 45 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2017 | 6203 | 0.070 |
Why?
|
| Temperature | 2 | 2011 | 2226 | 0.070 |
Why?
|
| Oxides | 1 | 2009 | 402 | 0.070 |
Why?
|
| Avidin | 1 | 2007 | 44 | 0.070 |
Why?
|
| Alkynes | 1 | 2008 | 326 | 0.070 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2007 | 110 | 0.070 |
Why?
|
| Heparin | 1 | 2014 | 1630 | 0.070 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2007 | 60 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2017 | 1940 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 6113 | 0.070 |
Why?
|
| Titanium | 1 | 2009 | 490 | 0.070 |
Why?
|
| Liver Cirrhosis | 2 | 2019 | 1959 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 14652 | 0.070 |
Why?
|
| Sulfhydryl Compounds | 1 | 2008 | 296 | 0.070 |
Why?
|
| Mitochondrial Proteins | 2 | 2013 | 975 | 0.070 |
Why?
|
| Amines | 1 | 2008 | 281 | 0.070 |
Why?
|
| Blood Vessels | 1 | 2012 | 1113 | 0.070 |
Why?
|
| Prostheses and Implants | 1 | 2013 | 1273 | 0.070 |
Why?
|
| Cricetulus | 1 | 2008 | 805 | 0.070 |
Why?
|
| Embryonic Stem Cells | 2 | 2010 | 1241 | 0.070 |
Why?
|
| Animals, Genetically Modified | 1 | 2011 | 1560 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 10729 | 0.070 |
Why?
|
| Spiral Ganglion | 1 | 2007 | 180 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3807 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 4348 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 2329 | 0.060 |
Why?
|
| Receptors, IgG | 1 | 2009 | 559 | 0.060 |
Why?
|
| Biophysical Phenomena | 1 | 2007 | 318 | 0.060 |
Why?
|
| Virus Internalization | 1 | 2010 | 502 | 0.060 |
Why?
|
| Photons | 2 | 2006 | 572 | 0.060 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 399 | 0.060 |
Why?
|
| CHO Cells | 1 | 2008 | 1372 | 0.060 |
Why?
|
| Biophysics | 1 | 2007 | 375 | 0.060 |
Why?
|
| Biomimetics | 1 | 2007 | 168 | 0.060 |
Why?
|
| Neurites | 1 | 2007 | 389 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 697 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 2194 | 0.060 |
Why?
|
| Paracrine Communication | 1 | 2007 | 277 | 0.060 |
Why?
|
| Medicine | 1 | 2013 | 942 | 0.060 |
Why?
|
| Cell Physiological Phenomena | 1 | 2006 | 148 | 0.060 |
Why?
|
| Blood Transfusion | 1 | 2012 | 1297 | 0.060 |
Why?
|
| Cytochrome P-450 CYP2B1 | 1 | 2004 | 22 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2005 | 12131 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 1995 | 0.060 |
Why?
|
| Endocytosis | 1 | 2009 | 950 | 0.060 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2005 | 36 | 0.060 |
Why?
|
| Motion | 2 | 2009 | 781 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2013 | 1668 | 0.060 |
Why?
|
| Decorin | 1 | 2004 | 38 | 0.060 |
Why?
|
| Organ Specificity | 1 | 2009 | 1965 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2006 | 3513 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6499 | 0.060 |
Why?
|
| Cricetinae | 1 | 2008 | 2411 | 0.060 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 2536 | 0.060 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2005 | 136 | 0.060 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2004 | 117 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2011 | 1797 | 0.060 |
Why?
|
| Safety | 2 | 2016 | 1157 | 0.060 |
Why?
|
| Brain Injuries | 1 | 2016 | 2060 | 0.060 |
Why?
|
| Rheology | 2 | 2003 | 348 | 0.060 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2004 | 110 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2013 | 3633 | 0.060 |
Why?
|
| BRCA1 Protein | 1 | 2010 | 1153 | 0.060 |
Why?
|
| Computer Simulation | 3 | 2016 | 6255 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2009 | 750 | 0.050 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2003 | 14 | 0.050 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2007 | 729 | 0.050 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2004 | 246 | 0.050 |
Why?
|
| Cell Nucleus | 3 | 2018 | 2867 | 0.050 |
Why?
|
| Environment | 1 | 2009 | 1114 | 0.050 |
Why?
|
| Glass | 2 | 2012 | 116 | 0.050 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2005 | 437 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2015 | 8927 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2015 | 3047 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 2428 | 0.050 |
Why?
|
| Silicon Compounds | 1 | 2002 | 16 | 0.050 |
Why?
|
| Luminescence | 2 | 2016 | 110 | 0.050 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2002 | 55 | 0.050 |
Why?
|
| Polystyrenes | 3 | 2008 | 102 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 2844 | 0.050 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2005 | 222 | 0.050 |
Why?
|
| Cell Size | 1 | 2004 | 625 | 0.050 |
Why?
|
| Integrins | 1 | 2006 | 840 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2009 | 1341 | 0.050 |
Why?
|
| Electrodes | 1 | 2004 | 609 | 0.050 |
Why?
|
| Regeneration | 2 | 2013 | 1517 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 1602 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2018 | 3785 | 0.050 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2012 | 1663 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2010 | 1084 | 0.050 |
Why?
|
| Stress, Mechanical | 2 | 2004 | 1669 | 0.050 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2004 | 366 | 0.050 |
Why?
|
| Venous Thromboembolism | 1 | 2014 | 1882 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2004 | 793 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2006 | 718 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2013 | 10070 | 0.050 |
Why?
|
| Chondrocytes | 1 | 2006 | 799 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2018 | 65189 | 0.040 |
Why?
|
| Iron | 1 | 2009 | 1816 | 0.040 |
Why?
|
| DNA Damage | 1 | 2010 | 2457 | 0.040 |
Why?
|
| Photography | 1 | 2003 | 533 | 0.040 |
Why?
|
| Antineoplastic Agents | 4 | 2011 | 13648 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2015 | 14447 | 0.040 |
Why?
|
| Mitochondria | 1 | 2013 | 3673 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 1102 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2019 | 4258 | 0.040 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2019 | 59 | 0.040 |
Why?
|
| Cartilage, Articular | 1 | 2006 | 1089 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 2548 | 0.040 |
Why?
|
| Culicidae | 1 | 2019 | 110 | 0.040 |
Why?
|
| Male | 9 | 2019 | 363691 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7599 | 0.040 |
Why?
|
| Algorithms | 3 | 2015 | 14071 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 8529 | 0.040 |
Why?
|
| Oogenesis | 1 | 2019 | 125 | 0.040 |
Why?
|
| Genome | 1 | 2006 | 1753 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2002 | 550 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2018 | 9249 | 0.040 |
Why?
|
| Robotics | 1 | 2005 | 809 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2019 | 124 | 0.040 |
Why?
|
| Mycoplasma hyorhinis | 1 | 2017 | 8 | 0.040 |
Why?
|
| Gammaproteobacteria | 1 | 2017 | 28 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 3602 | 0.040 |
Why?
|
| Karyopherins | 1 | 2018 | 134 | 0.040 |
Why?
|
| Carcinoma | 1 | 2009 | 2312 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 6069 | 0.030 |
Why?
|
| Liver Regeneration | 1 | 2019 | 214 | 0.030 |
Why?
|
| Swine | 3 | 2002 | 5988 | 0.030 |
Why?
|
| Neurons | 1 | 2016 | 9524 | 0.030 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 2016 | 15 | 0.030 |
Why?
|
| Antigens | 1 | 2002 | 1438 | 0.030 |
Why?
|
| Antibodies, Protozoan | 1 | 2018 | 250 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 5696 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 1998 | 522 | 0.030 |
Why?
|
| Azabicyclo Compounds | 1 | 2016 | 66 | 0.030 |
Why?
|
| Transplantation, Isogeneic | 1 | 2016 | 251 | 0.030 |
Why?
|
| Urea | 1 | 1998 | 448 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2016 | 157 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 15398 | 0.030 |
Why?
|
| Proteomics | 1 | 2009 | 3910 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2008 | 4913 | 0.030 |
Why?
|
| Quorum Sensing | 1 | 2016 | 137 | 0.030 |
Why?
|
| Culture Media | 1 | 1997 | 890 | 0.030 |
Why?
|
| Haplorhini | 1 | 2015 | 520 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 461 | 0.030 |
Why?
|
| Polylysine | 1 | 1994 | 130 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2009 | 3459 | 0.030 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2015 | 142 | 0.030 |
Why?
|
| Antibodies | 1 | 2002 | 2417 | 0.030 |
Why?
|
| Polyurethanes | 1 | 1994 | 112 | 0.030 |
Why?
|
| Microscopy, Atomic Force | 1 | 1994 | 250 | 0.030 |
Why?
|
| Viscosity | 1 | 1994 | 334 | 0.030 |
Why?
|
| Synthetic Biology | 1 | 2016 | 186 | 0.030 |
Why?
|
| Serum Albumin, Bovine | 1 | 1994 | 318 | 0.030 |
Why?
|
| Rabbits | 2 | 2015 | 4734 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15880 | 0.030 |
Why?
|
| Steroids | 1 | 2019 | 933 | 0.030 |
Why?
|
| Organ Size | 1 | 2019 | 2261 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 1130 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2018 | 903 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 536 | 0.030 |
Why?
|
| Surface-Active Agents | 2 | 2004 | 150 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2014 | 272 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1885 | 0.030 |
Why?
|
| Brain | 2 | 2016 | 27178 | 0.030 |
Why?
|
| Dynamins | 1 | 2013 | 138 | 0.030 |
Why?
|
| Exons | 1 | 2018 | 2391 | 0.020 |
Why?
|
| Reference Standards | 1 | 2016 | 1013 | 0.020 |
Why?
|
| Brazil | 1 | 2016 | 1248 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2013 | 914 | 0.020 |
Why?
|
| Cell Count | 1 | 2016 | 1823 | 0.020 |
Why?
|
| Capillaries | 1 | 2015 | 755 | 0.020 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2013 | 280 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2014 | 2163 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 29921 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1638 | 0.020 |
Why?
|
| KB Cells | 1 | 2010 | 12 | 0.020 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2011 | 164 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2011 | 204 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 1947 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2018 | 2666 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2016 | 3586 | 0.020 |
Why?
|
| Cetrimonium Compounds | 1 | 2010 | 4 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 24283 | 0.020 |
Why?
|
| Dogs | 1 | 2015 | 3822 | 0.020 |
Why?
|
| Carbohydrates | 1 | 2012 | 386 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2004 | 5089 | 0.020 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2010 | 71 | 0.020 |
Why?
|
| Microcirculation | 1 | 2015 | 1280 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2019 | 2056 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 523 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2016 | 2341 | 0.020 |
Why?
|
| India | 1 | 2016 | 2334 | 0.020 |
Why?
|
| Suspensions | 1 | 2009 | 66 | 0.020 |
Why?
|
| Erythrocyte Aggregation | 1 | 2009 | 35 | 0.020 |
Why?
|
| Exosomes | 1 | 2014 | 421 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2013 | 931 | 0.020 |
Why?
|
| Pancreas | 1 | 2016 | 1700 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2011 | 898 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1884 | 0.020 |
Why?
|
| Lentivirus | 1 | 2011 | 518 | 0.020 |
Why?
|
| Kupffer Cells | 1 | 2009 | 144 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2013 | 1735 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2011 | 745 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2008 | 157 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2009 | 541 | 0.020 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2009 | 122 | 0.020 |
Why?
|
| Computer Systems | 1 | 2010 | 466 | 0.020 |
Why?
|
| Models, Structural | 1 | 2008 | 338 | 0.020 |
Why?
|
| Optical Phenomena | 1 | 2008 | 103 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2012 | 1216 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 1061 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 1066 | 0.020 |
Why?
|
| Interferons | 1 | 2011 | 714 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 1 | 2009 | 349 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 1385 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 9601 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2012 | 752 | 0.020 |
Why?
|
| Cell Shape | 1 | 2008 | 373 | 0.020 |
Why?
|
| Microtubules | 1 | 2013 | 1062 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 2009 | 1430 | 0.020 |
Why?
|
| Zebrafish | 1 | 2019 | 3035 | 0.020 |
Why?
|
| Dextrans | 1 | 2009 | 571 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 11022 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2009 | 939 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2008 | 328 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2016 | 2573 | 0.020 |
Why?
|
| Interleukins | 1 | 2011 | 791 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 1892 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 2006 | 288 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 1314 | 0.020 |
Why?
|
| Plasma | 1 | 2009 | 579 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 20660 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2017 | 2339 | 0.020 |
Why?
|
| Actins | 1 | 2013 | 2056 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 1072 | 0.020 |
Why?
|
| Heating | 1 | 2006 | 103 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 2531 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2001 | 8041 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 390 | 0.010 |
Why?
|
| Sex Factors | 1 | 2019 | 10602 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2016 | 8278 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 74836 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 2012 | 1672 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 2394 | 0.010 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 416 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 5783 | 0.010 |
Why?
|
| Volatilization | 1 | 2003 | 75 | 0.010 |
Why?
|
| Biological Transport | 1 | 2008 | 2081 | 0.010 |
Why?
|
| Apoptosis | 1 | 2019 | 9514 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 17594 | 0.010 |
Why?
|
| Goats | 1 | 2002 | 166 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 36532 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2007 | 2669 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2003 | 642 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2010 | 2920 | 0.010 |
Why?
|
| Polyethylene | 1 | 2003 | 184 | 0.010 |
Why?
|
| Semiconductors | 1 | 2002 | 99 | 0.010 |
Why?
|
| Software | 1 | 2015 | 4462 | 0.010 |
Why?
|
| Microspheres | 1 | 2004 | 773 | 0.010 |
Why?
|
| Optics and Photonics | 1 | 2003 | 305 | 0.010 |
Why?
|
| Biopsy | 1 | 2013 | 6763 | 0.010 |
Why?
|
| Polyesters | 1 | 2003 | 372 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 2003 | 443 | 0.010 |
Why?
|
| Molecular Probes | 1 | 2002 | 307 | 0.010 |
Why?
|
| DNA Repair | 1 | 2010 | 2048 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 762 | 0.010 |
Why?
|
| Endothelium | 1 | 2002 | 767 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2002 | 675 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2686 | 0.010 |
Why?
|
| Caffeine | 1 | 2003 | 702 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 12769 | 0.010 |
Why?
|
| United States | 2 | 2017 | 72898 | 0.010 |
Why?
|
| Protein Binding | 1 | 2009 | 9296 | 0.010 |
Why?
|
| Ethanol | 1 | 2003 | 1323 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 8102 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 2631 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 20125 | 0.010 |
Why?
|
| Pressure | 1 | 1999 | 1168 | 0.010 |
Why?
|
| Proteins | 1 | 2009 | 5995 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2009 | 2659 | 0.010 |
Why?
|
| Aged | 2 | 2017 | 171114 | 0.010 |
Why?
|
| Middle Aged | 2 | 2017 | 223004 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 12807 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 59886 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 18071 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 88832 | 0.000 |
Why?
|
| Mutation | 1 | 2013 | 30196 | 0.000 |
Why?
|
| Lung | 1 | 2002 | 10033 | 0.000 |
Why?
|
| Adult | 1 | 2017 | 223038 | 0.000 |
Why?
|